Report: Charles Schwab - LOM - Endovasc - James Dale Davidson,Belladorgroup,etc.
Category: Brokerage Companies
Charles Schwab - Schwab Capital - LOM - Endovasc offshores ripoff San Francisco, Bermuda California
*UPDATE *UPDATE ..Charles Schwab Statement To The SEC On Penny Socks,1999
Rebuttal Box
Respond to this report!
Are you an owner, employee or ex-employee with either negative or positive information about the company or individual, or can you provide "insider information" on this company? Victim of this person/company?
Are you also a victim of the same company or individual? Want Justice? File a Rip-off Report, help other consumers to be educated and don´t let them get away with it!
Charles Schwab - LOM - Endovasc - James Dale Davidson,Belladorgroup,etc.
Fax:
San Francisco, California,
U.S.A.
Submitted: 10/5/2004 5:01:02 PM
Modified: 12/21/2004 1:19:41 AM
Tony
Antigua, Central AmericaEVSC: Director; Auditors; Shr Increase
Tuesday , October 05, 2004 13:49 ET
According to a PRE 14A filed today, the Annual Meeting of Shareholders of Endovasc Inc (OTCBB: EVSC) is tentatively scheduled (subject to approval) to be held on November 19, 2004 at 2 pm, local time, at Havens Landing, 19785 Highway 105 West, Montgomery, Texas, at which the Company intends to seek approval for the following:
1. To elect one director to serve for a three-year term and until his or her successor is elected and qualified.
2. To ratify the selection of Ham, Langston & Brezina LLP as independent auditors for the fiscal year ending June 30, 2005.
3. To amend the Company's Articles of Incorporation to increase to 400,000,000 the number of shares of Common Stock, $.001 par value per share, we are authorized to issue.
4. To transact such other business as may properly come before the Annual Meeting or any adjournments thereof.
This preliminary information is subject to regulatory approval.
Tony
Antigua
Guatemala
Looking for premium tickets? Concert Tickets | Sports Tickets | Theatre Tickets just visit www.TicketFeeder.com
Search for additional reports
If you would like to see more Rip-off Reports on this company/individual, please use the search box below:
In order to assure the best results in your search:
- Keep the name short & simple, and try different variations of the name.
- Do not include ".com", "S", "Inc.", "Corp", or "LLC" at the end of the Company name.
- Use only the first/main part of a name to get best results.
- Only search one name at a time if Company has many AKA’s.
Rebuttal Box
Respond to this report!
Are you an owner, employee or ex-employee with either negative or positive information about the company or individual, or can you provide "insider information" on this company? Victim of this person/company?
Are you also a victim of the same company or individual? Want Justice? File a Rip-off Report, help other consumers to be educated and don´t let them get away with it!Repair Your Reputation
Got Reports filed against you? Resolve the issues and rebuild trust through our Corporate Advocacy Program.
Updates & Rebuttals:
- I should never have touched a penny stock, but in retrospect I should never have touched a computer Tony [10/5/2004 5:39:30 PM]
- Schwab Protects Insider Pump Dump and Cover-up. Why ? Tony [10/6/2004 3:45:26 PM]
- NAANSS or How Attorney O'Quinn Aided Massive Penny Stock Fraud and the 'Penny Mafia' Tony [10/7/2004 3:36:56 PM]
- Judge Ken Reilly Lies ,James Davidson Denies: Securities and Political Fraud Tony [10/7/2004 8:42:26 PM]
- Correspondence from Davidson, 'Dr.'Summers,Alexander Walker and some SEC statements etc. Tony Ryals [10/8/2004 5:22:01 PM]
- No one forced him into buying the stock Charles [10/25/2004 7:27:20 PM]
- Tony Ryals is an idiot- Part 2 Charles [10/26/2004 11:47:04 PM]
- More details re the Schwab-LOM account and it's use for pump dump. Tony [11/20/2004 5:28:43 PM]
- Bellador Group of Kuala Lumpur Tony [11/25/2004 12:48:12 AM]
- This guy is a crazy Sally [12/8/2004 10:18:09 PM]
- LOM,Mr.Lines,Schwab,et.al. Pump Dump Accounts ,and Florida Hotels Tony [12/17/2004 8:54:51 PM]
- Charles Schwab Statement To The SEC On Penny Socks,1999 Tony [12/20/2004 6:11:29 PM]
Submitted: 10/5/2004 5:39:30 PM
Modified: 10/5/2004 9:03:31 PM
Tony
Antigua, Central AmericaGuatemala
I should never have touched a penny stock, but in retrospect I should never have touched a computer
Dear Securities Fraud Reader,
In retrospect I should never have touched a penny stock, but in retrospect I should never have touched a computer.And I was used to reading books that had no reason to lie to me in real time as I discovered on the internet.To me Schwab's 'strong buys' posted by the likes of 'Robertson Stephens' and myriad 'analysts' on the Schwab board in 2002 are little different from reading ragingbull message boards for advice.You see,in my ignorance the 'strong' tech buys turned to penny stock,albeit NASDAQ ones,and I didn't know the difference.
About Endovasc,it was the Stanford patent that lured me into the pump dump of James Dale Davidson et.al.,and perhaps 'LOM' of Bermuda as well, which would have been a Schwab account,at least in part,they were dumping from.Anyway the 'shareholder agreement' posted below was used for that purpose through a Schwab account whether it is the LOM of Bermuda account or not.Only later,(this year),would I discover just how sleezy this Montgomery,Texas pump dump called Endovasc really was as they made boiler room deals with the likes of Belladorgroup.com boiler room operation out of Kuala Lumpur that has an unenviable reputation amongst Hong Kong securities officials,who unlike our SEC apparently, who warn their own citizens about it.
Paradoxical for a company 'management' who under pretenses of 'patriotism' after 9/11 claimed to be buying shares back to help investors.But in truth,working with any stock scamsters,including in areas of the world where shares can be used to mask undeworld criminal or even terrorist causes and no one would ever know.
As to penny stocks I would say it is hard indeed to predict when they will fly but most of the time is a slower but continual downward move in share price as management dumps more shares.Only when insiders are ready to dump does the touting begin which,as touting goes,is nothing but lies and hot air.Which is about all most of them sell.
And you see in the case of Endovasc and its insiders, they lied and lied constantly, blaming the drop in share price literally on Schwab and other market makers who they claimed 'naked shorted' them and me.The truth,as it turned out,was even worse to me.Schwab was hosting a dump account for the very ones who were masking it by crying 'naked short' !!!! In many ways Charles Schwab the broker AND market maker were working hand in hand with the pump dump fraudsters.
Schwab,unless it has something to hide,should have been exposing them,(whoever Endovasc 'management' conspired with to fill a Schwab account with shares to dump when J.D.Davidson touted),and NOT covering up for them. why ? So you see,mystery remains.
And so as I will try and make clear in the documentation I post as a complaint on ripoffreport.com that Charles Schwab in many ways introduced me to a penny mafia, purposefully or not,within a year of buying the first stock in my life.
..........................................................
This article from DowJones' Carol Remond of June this year informed me for the first time of a Schwab account held by LOM of Bermuda.I had already received from Schwab,in response to a complaint to the SEC,a 'shareholder agreement' between Ensdovasc and a Schwab client to fill an anonymous Schwab account with up to 30 million shares in May 2002 !! This was many times over all shares that should have existed in light of an announced 40 for 1 'reverse split'.Someone(s) with that account had been selected to have the shares in their Schwab account gain 40 times in value overnight while unbeknownst to me I was about to be the victim of a phony reverse split and a pump dump scheme orchestrated mainly, it would appear,by one James Dale Davidson of 'Clinton killed Vince Foster and CIA Chief Wiliam Colby fame,a political as well as the securities fraudster.Davidson,as you will see by following along,has a 'LOM' connection.
'LOM had brokerage accounts with at least four U.S. brokerage firms, including Knight Securities LP, Paragon Capital Markets Inc., Wein Securities Corp. and Vfinance Investments Inc., the SEC said. The firm also has accounts at Sterne, Agee Capital Markets Inc. and Schwab Capital Markets LLC.'
14 Jun 2004 17:39 ET =DJ IN THE MONEY: SEC Seeks Information From Bermuda Brokerage
By Carol S. Remond
A Dow Jones Newswires Column
NEW YORK (Dow Jones)--The Securities and Exchange Commission last week filed court documents to compel Bermuda-based brokerage firm Lines Overseas Management Ltd., or LOM, to comply with several requests for information in connection with two SEC investigations.
The SEC is trying to force LOM to produce information related to ongoing investigations into HiEnergy Technologies Inc. (HIET) and Sedona Software Solutions Inc. (SSSI). The SEC began investigating Sedona in January 2003. At that time, it temporarily suspended trading in Sedona shares because of questions about the accuracy and completeness of information about the company on Internet websites and press releases, concerning among other things, the company's planned merger with Renaissance Mining Corp. Meanwhile, the Commission began investigating HiEnergy in April 2003.
Court documents filed in the U.S. District Court for the District of Columbia show the SEC subpoenaed LOM and Scott Lines, LOM's managing director, in April 2004.
The SEC is looking for 'documents relating to (LOM's) relationships with three issuers, whose Securities are registered with the Commission and traded on U.S. markets, and the trading activity in the securities of those issuers conducted through accounts at LOM,' court filings show.
LOM wasn't immediately available for comment but a person answering the telephone at the firm's number in Bermuda said the brokerage would soon issue a press release.
According to the SEC, LOM, which is based in the Bermuda and also has offices in the Cayman Islands and in the Bahamas, routinely trades U.S. securities on behalf of its customers and officers, including Scott and his brother Brian Lines who is president and a director of the firm. As of January 2003, LOM had brokerage accounts with at least four U.S. brokerage firms, including Knight Securities LP, Paragon Capital Markets Inc., Wein Securities Corp. and Vfinance Investments Inc., the SEC said. The firm also has accounts at Sterne, Agee Capital Markets Inc. and Schwab Capital Markets LLC.
Court Documents filed by the SEC show that it's investigating possible securities laws violations in Sedona and HiEnergy stocks. The SEC also said that during its Sedona investigation, the 'staff identified apparent fraud, market manipulation and reporting violations in the securities of a third U.S. registrant' called SHEP Technologies Inc. (STLOF).
The SEC said that during its investigations it 'developed facts which indicate that significant trading in the securities of each of these three U.S. registrants occurred on U.S. markets through accounts at LOM, which used its own accounts at U.S. firms and its depository and clearing agreements with U.S. firms to execute the trades for the benefit of LOM customers and Brian and Scott Lines personally.'
The SEC said it served Scott Lines in person at Miami International Airport on April 20, 2004 and that neither Lines nor his firm contested the service or the validity of the subpoenas. The subpoenas requested that LOM and Lines produce 'documents related to the trading in HiEnergy, Sedona and Shep securities for the period of January 1 2002 through the present.' The SEC asked LOM and its managing director to produce the information by April 28 and to appear for testimony in Washington, D.C., on May 4 and 5, 2004. 'To date, Lines and LOM have failed to comply with the subpoenas in every respect,' the SEC said in a court filing.
It's unclear whether the SEC will succeed in obtaining the information it's seeking from LOM.
A declaration by an SEC attorney filed in court shows that LOM has claimed through counsel that it's prohibited from producing documents under the laws of the Bahamas, Bermuda and/or the Cayman Islands.
With respect to HiEnergy, the SEC contends that documents requested from LOM and Lines are relevant because they could help the SEC establish whether convicted felon and securities violator 'Philip Gurian or related persons or entities profited from Gurian's fraudulent undisclosed control of HiEnergy by selling its stock through LOM, and whether any person or entity, including possibly Gurian or LOM, manipulated HiEnergy Stock.'
The SEC investigation into HiEnergy came shortly after a Dow Jones 'In The Money' Column that highlighted connections between two of the company's investors and Gurian. Gurian pleaded guilty in 2000 to federal charges that included mail fraud and conspiracy to commit securities fraud.
(Carol S. Remond is one of four 'In The Money' columnists who take a sophisticated look at the value of companies
and their securities and explore unique trading strategies.)
-By Carol S. Remond; Dow Jones Newswires; 201 938 2074; carol.remond@dowjones.com
(END) Dow Jones Newswires
...........................................................
FROM ENDOVASC WEBSITE CIRCA 2001:
QUESTION 6/20/01 - Is ENDV dropping like a stone because discount convertible preferred holders in the Camen Islands are shorting the #### out of it against the box? In other words is ENDV really legit... I am asking myself, or did I get scammed?
ANSWER - ENDV is a legitimate company which operates from offices in Montgomery,Texas. ENDV continues to meet the SEC guidelines for reporting and those reports can be accessed on the SEC website. Unfortunately, the OTC is a risky place to be both as an investor and a company. Which is why listing on Nasdaq continues to be a goal of ENDV.
..........................................................
BELOW IS FROM SEC COMPPLAINT RE AGORA PUBLICATIONS OF WHICH JAMES DALE DAVIDSON IS FOUNDER :
James Dale Davidson is the editor of Agora's Vantage Point Investment Advisory, a financial newsletter with a worldwide circulation. In December 2002 and January 2003, Agora distributed e-mails written by Davidson to its subscriber base. These e-mails promote several unnamed microcap issuers and offer to provide reports naming these issuers if the recipient of the e-mail paid $149 to subscribe to the Vantage Point newsletter.
42. Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. Davidson is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses Davidson's relationship to the companies.
FIRST CLAIM FOR RELIEF
..........................................................
James Dale Davidson,Lines Overseas Management, and MIV, etc.:
Mr.Davidsion who was a significant shareholder in 'LOM' or Line Overseas Management at one time recommended it for offshore 'financial services' in 'The Soveriegn Individual' that he co-authored with the Lord Rees-Mogg former editor of the London Financial Times and now ,ha ha,of 'newsmax.com'.Note the association with Davidson and 'LOM' below in regards to MIVT and its stock,one of the many penny stocks he pump dumps,etc. New Paradigm Capital Ltd.also of Burmuda is a Davidson operation as well:
May 30, 2001
DBS HOLDINGS INC (DBSH.OB)
form 8-K
ITEM 1 and 2. CHANGES IN CONTROL OF REGISTRANT/ACQUISITION OR DISPOSITION OF
ASSETS
A. Transaction -
On April 25, 2001, the Company entered into a Share Exchange and Finance Agreement (the 'Agreement') with M-I Vascular Innovations, Inc., ('MIV'), a private Delaware company, and certain shareholders of MIV (the 'MIV Shareholders'). The Agreement closed effective as of May 15, 2001 as the Agreement was signed by the requisite number of MIV Shareholders permitting the Company to own over 51% of the MIV shares as contemplated by Section 11.11 of the Agreement. This resulted in a take-over of MIV by the Company which is effectively a reverse take-over of the Company as the MIV Shareholders now control a majority of the outstanding shares of the Company. As a consequence, as more fully explained in the Agreement and in a Schedule 13D recently filed by some of the former shareholders of the Company, control of the Company shifted from the founders of the Company (including Mr. Daniel Steunenberg, Madeline Stanley, Ken Paul, Irma Paul, Eli Stratulat, Alex Basic and Chansu Financial) to the MIV Shareholders (the principal members being Isaiah Capital Ltd., Stephen Walters, Carlingford Assets Limited, James Davidson, New Paradigm Capital Ltd., and Lines Overseas Management). The change of control resulted from the combined effect of (i) a redemption of all of the Common Stock held by Mr. Daniel Steunenberg, Madeline Stanley, Ken Paul, Irma Paul, Eli Stratulat, Alex Basic and Chansu Financial which reduced the number of outstanding shares of the Company to 5,419,500, and (ii) the issuance of Common Stock by the Company in a one-for-one exchange for the shares of MIV stock held by the MIV Shareholders which increased the number of outstanding shares to 14,639,500. The terms of the redemption and stock exchange were determined by arm's length negotiation among the Company, MIV and the MIV Shareholders. The issuance of Common Stock to the MIV Shareholders was exempt from registration under the Securities Act of 1933 pursuant to ss.4(6) and Regulation S promulgated thereunder. As a result, the MIV Shareholders now own a total of 9,220,000 shares (ie. approximately 63%) of the outstanding Common Stock of the Company. Management believes that most, if not all of the remaining shareholders of MIV will exchange their shares, for shares of the Company in the near future.
The Agreement contemplates that outstanding or promised warrants or options to purchase MIV stock owned by or owed to the shareholders of MIV and their affiliates, if any, shall be exchanged for comparable warrants or options to purchase an equal number of shares of the Company's stock of the shareholders of MIV accepting the exchange.
...........................................................
from ragingbull message boards:
By: Mighty_Mezz ,from gmxx board on ragingbull:
20 Aug 2003, 08:19 PM EDT
Msg. 35150 of 35150
Jump to msg. #
For those following the antics of James Davidson.
He's now a director of BEVIE, formerly BEVS, BEVSE, BEVI - recent 1 for 100 reverse split.
He recently was allowed to buy 3 million shares at a penny. The pump and dump is underway.
...........................................................
'James Davidson, portrays himself as an outspoken opponent of naked short-sellers. As we have pointed out in the past, one of the worst enemies of emerging companies and the best friend of the naked short-sellers are the discount based convertible fundings better known as 'toxic fundings' or 'death spirals'. Given these facts, we would like to call everyone's attention to the fact that a group called the Advantage Fund, I, LLC recently cut a deal with ChampionLyte at a conversion factor of 70% of the bid and the very same Advantage Fund I, LLC can be found as a significant holder and seller of BEVsystems shares as well. Who besides James Dale Davidson was connected to both these companies in a way that could get this funding handled for the Advantage Fund I, LLC. Could it be that Mr. Davidson is a wolf in sheep's clothing? Or is someone running around companies where he is a director and/or significant shareholder and pushing these death spirals through over his vehement objections?
'It should be further noted that The Advantage Fund I, LLC also shares the same address with ChampionLyte Holdings, and Kinghtsbridge Capital and that these two funding groups are related to not only this address but also the address of Finantra Capital and Mr. Robert Press who of course partnered up with Davidson for the takeover of ChampionLyte. Of course none of this is disclosed but you have a right to know!
Our-street.com copyright 2003
..............................................................................................................................
CONTRADICTIONS FROM DAVIDSON'S OWN PUBLICATIONS WITH REGARD TO SIZE OF HIS ENDOVASC SHARE HOLDINGS AROUND TIME OF HIS PUMP DUMP:
'This week Endovasc Inc. (EVSC) (of which Mr. Davidson is a substantial shareholder) announced some very interesting results from a study that it had conducted. These results could push Endovasc's entry into the non-steroidal muscle growth supplement market.'
Dale Davidson's most recent lie?('substantial shareholder'?)......Then Below he says:
'I had a painful lesson in this reality at the beginning of this week when I learned to my astonishment that the Utah office of the SEC had tarnished my name by accusing me of failing to disclose an interest in two investments that I recommended in Vantage Point Investment Advisory. Their exact charge is as follows:
'Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. Davidson is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses Davidson's relationship to the companies.'
This is total rubbish. I deny any impropriety. Indeed, the charges are remote from the facts.
As you will know if you subscribed to Vantage Point last summer, I fully disclosed my role as a founder, director and officer of GeneMax when I recommended the company and its promising treatment for cancer. And I also disclosed a special relationship with Endovasc. I am not an officer or director of Endovasc. I have a few shares that I received in exchange for assigning my rights in what could be a
valuable patent to the company.' (end Davidson rant )
Is Dale Davidson's Vantage Point statement of April he says, re Endovasc, that he has a 'few' endovasc shares (from plagiarizing a Stanford patent?).then there's his statement re being a 'substantial shareholder'.? I get confused, but apparently he, like Dr. Summers,does as well.They seem to be confused over the complexities of their own lies....
...............................................................................................................................
41. For example, James Dale Davidson is the editor of Agora's Vantage Point Investment Advisory, a financial newsletter with a worldwide circulation. In December 2002 and January 2003, Agora distributed e-mails written by Davidson to its subscriber base. These e-mails promote several unnamed microcap issuers and offer to provide reports naming these issuers if the recipient of the e-mail paid $149 to subscribe to the Vantage Point newsletter.
42. Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. Davidson is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses Davidson's relationship to the companies.
FIRST CLAIM FOR RELIEF
SEC COMPLAINT RE DAVIDSON,EVSC 'MANAGEMENT' FRAUD.
The strange thing about the SEC complaint is that Mr.Davidson is not charged with running a pump dump.He not only touts or promotes the stock to increase spuculation and share price but he admits having shares to dump as well.He is not only charging for 'adise' to buy Endovasc shares but profiting from Endovasc share dumping as well.
............................................................
Daily Reckoning Editor's Note: James Dale Davidson has enjoyed astounding personal success founding new companies in a variety of industries. A graduate of Oxford University, Mr. Davidson is also a renowned venture capitalist and the author of bestsellers such as Blood In The Streets and The Great Reckoning. Davidson's latest research and investment picks can be found in his monthly newsletter, Vantage Point Investment Advisory.
('Daily Reckoning' is part of Davidson's cyberfraud machine,in my opinion.He often uses it for self promotion of his penny scams.etc.)
...........................................................
FROM RECENT ARTICLE ON LOM BY CAROLE REMOND :
'As of January 2003, LOM had brokerage accounts with at least four U.S. brokerage firms, including Knight Securities LP, Paragon Capital Markets Inc., Wein Securities Corp. and Vfinance Investments Inc., the SEC said. The firm also has accounts at Sterne, Agee Capital Markets Inc. and Schwab Capital Markets LLC.'
from Carole Remond DJ's In The Money,June 2004
................................................................................................................
Much of this material was meant in 2003 to be a ripoffreport complaint or article related to the loss of my entire investment in the Montgomery, Texas fraud biotech 'company' called Endovasc and its silent fraudulent consultant or audit committee member,or whatever he was to that scam,James Dale Davidson.It might,in retrospect be titled,at least in part,'How Charles Schwab Introduced Me To The Penny Mafia' or perhaps 'The Person who Fell Into A Computer', because that's how I feel here in Guatemala where I thought they could never touch me.I have even come to coin my own term about the nightmare and fraud I have experienced and endured from all those involved.I call it 'share-money laundering'.And although it goes on with unsaid numbers of defrauded individuals and untold millions of dollars,no one does anything about it.I could say right now that much of it could be ended by Charles Schwab and and its' Schwab Capital and other market makers were the fraud not such a lucrative business for them.And in not changing they are in violation or covering up a conduit for money laundering.
The Endovasc scam began for me in early 2001 with cyberfraud press releases like this below from Endovasc announcing well known cardiologist Antonio Colombo would administer human trials of its Stanford patented angiogenesis drug(nicotine)wthin a couple of months.This never happened,of course.I,with no stock experience,had already lost 3/4 of my inheritance due to all those 'strong buys' for 'tech stock' posted on the Charles Schwab board,particularly I remember a Robertson Stephens who was given carte blanche to tout on Schwab's website.
And once I had got into the 'tech' sector of the Schwab board its software always took me in a circle back to some similar 'tech stock' hyped by several 'analysts'. All these dollar stocks turned, or crashed, to penny stocks within a year of my buying the first stock,Heinz,on the telephone before Schwab suggested I go 'online'..By then I despised internet and computers so I fell for Endovasc's Stanford patent. Besides this Incubud hype below there were also businesswire press releases touting this same human trial of a Stanford patent for angiogenesis:
Endovasc Announces Completion of Dog Studies for Nicotine Receptor Agonist
MONTGOMERY, Texas--(BW HealthWire)--Feb. 26, 2001--
Endovasc Ltd. Inc. (OTCBB:ENDV - news) today announced the completion of further studies of its Nicotine Receptor Agonist (NRA) in dogs.
NRA has been proven to create new blood vessel growth (angiogenesis) in animals. Dr. Daniel Burkhoff, associate professor of medicine in the Division of Circulatory Physiology at Columbia University's College of Physicians and Surgeons, and an associate attending physician at the New York Presbyterian Hospital, has completed recent testing of NRA in dogs. With the positive results from the studies, Dr. Burkhoff will proceed with ischemic pig models, a study which is projected for completion in approximately 10 weeks.
The company is continuing animal studies and human clinical trials for the use of NRA as a non-surgical angiogenic therapy for blocked arteries to the heart, avoiding angioplasty and possibly even by-pass surgeries for this condition. According to Dr. David P. Summers, chairman and CEO of Endovasc, 'The use of NRA could create a 'biological by-pass' therapy, a revolutionary methodology for treating ischemic heart disease.'
Dr. Antonio Colombo, chief of investigational angioplasty at Lenox Hill Hospital in New York, and director of the cardiac catheterization laboratory at EMO Centro Cuore Columbus in Milan, will conduct the human pilot study for NRA in Italy in March of this year. This clinical trial will involve patients with diseased heart muscle resulting from a deficiency of blood caused by obstruction in the blood vessel (ischemic cardiomyopathy) and chronic or uncontrolled chest pain (intractable angina pectoris).
Endovasc Ltd. Inc. is a biopharmaceutical/biotech company pioneering liposomal drug delivery technology. The Company's products and processes, which include Liprostin™ (liposome encapsulated PGE-1), NRA (Nicotine Receptor Agonist, angiogenesis agent), stent-coating technology, and a biodegradable/resorbable stent, are covered by patents and trade secrets for competing in a multi-billion dollar market.
The foregoing statements are made under the 'Safe Harbor' Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements that involve risks and uncertainties that may not be evident at the time of this release. For more information about Endovasc Ltd. Inc.
Contact:
Endovasc Ltd. Inc.,
Jack Sorbi,
936/448-2222
jack@endovasc.com
www.endovasc.com
The information on these pages is intended solely for the benefit of entrepreneurs and companies seeking business development assistance.
Copyright © 1999-2001 InCuBUD, Inc. All rights reserved.
Do not duplicate without express written permission.
For more information: Contact InCuBUD.
...........
Submitted: 10/6/2004 3:45:26 PM
Modified: 10/6/2004 11:15:36 PMTony
Antigua, Central AmericaGuatemala
Schwab Protects Insider Pump Dump and Cover-up. Why ?
Needless to say I would experience my first 'pump dump' at the end of 2001 with my over half million shares having fallen from an approximate $60,000 worth at around 10 cents per share down to almost 3 cents and then with the post 9/11 tout or pr promotion the stock soared to 24 cents a share or over double my money within a few weeks !!! Still,I held my shares believing in the Stanford patent and not imagining I was in a pump dump, hardly knowing what one was.Much tout or pump 'chatter' appeared on ragingbull with many 'aliases' posting messages on Endovasc's message board at that time and new press releases picked up in pace and sensational claims of FDA APPROVALS AND TRIALS AND FDA ORPHAN DRUG STATUS AND ON AND ON.
EVEN THE DISCLOSURE OF THE DENIAL OF THAT ORPHAN DRUG STATUS BY THE FDA IN EARLY 2002 WAS WITHHELD FROM COMMON SHAREHOLDERS FOR SOME TIME NO DOUBT AS INSIDERS DUMPED SHARES ON DUPED 'INVESTORS' WHO BOUGHT SHARES FROM THE RETAILORS LIKE SCHWAB CAPITAL ET.AL., AS OPPOSED TO SCHWAB ET.AL.'S BROKERS' SELECT CLIENTS',THE VERY ONES WHO RAN THE PUMP DUMPS IN THE FIRST PLACE.THESE COMPANY ISIDERS AND 'SELECT CLIENTS' TO BOTH ENDOVASC AND SCHWAB GOT THEIR SHARES FOR FREE OR AT DEEP DISCOUNT IN COLLUSION WITH MANAGEMENT TO 'SHORT DUMP' ON DEFRAUDED INVESTORS THROUGH SCHWAB AND OTHER BROKER OR MARKET MAKER ACCOUNTS.
NO,SCHWAB,ET.AL. DID NOT PUT THE LIP STICK ON THESE PIGS.THEY MARKET FOR OFFSHORES, LIKE 'LOM' OR 'LINES OVERSEAS MANAGEMENT' OF BERMUDA AND THE ANONYMOUS CLIENTS THEY REPRESENT,SUCH AS JAMES DALE DAVIDSON.IN THIS WAY, SCHWAB ACTUALLY HAS INSIDER INFO ALONG WITH THE CON ARTISTS THEY COOPERATE WITH TO DUMP SHARES ON COMMON PENNY STOCK 'INVESTORS'.FRAUDULENT PAID PRS AND PROFFESSIOAL PENNY STOCK PROMOTORS LIKE DAVIDSON DO THAT,(PUT LIP STICK ON PIGS),FOR THEM.SCHWAB JUST TAKES THEM TO THE MARKET AND SELLS THEM RETAIL ON THE MARKET FOR THESE OFFSHORE LOAN SHARKS AND CON ARTISTS WHO ARE INDEED THEIR 'SELECT CLIENTS' IN THE PENNY STOCK TOUT MARKET.THEN THEY HELP SEND THE CASH OFFSHORE TO AVOID TAXES OR IRATE INVESTORS IN THE AMERICAN MARKET WHO WERE DEFRAUDED.
The following recent email between John Jaeger of Charles Schwab and myself is exemplary of the kind of relation NOT to have with a broker and a market maker.Clearly Charles Schwab is covering up for someone(s) who Elias Torrez of Schwab termed a 'select client' in early 2003 when he sent me a 'shareholders agreement' between Endovasc and their 'select client' to deposit 'up to thirty million shares' !!! into that 'select client's' Schwab account for free !!!! And that deal had been made almost a year earlier in May 2002 when Endovasc was announcing a reverse split of stock for July 2002 !!!!
And this belated notification in 2003 for a transaction occuring in 2002 was only given to me because I complained to the SEC,still not knowing if I had been 'naked shorted' by my broker Schwab,as Edovasc,James Dale Davidson and 'famed trial attorney O'Quinn claimed in press releases of late 2002,or if Endovasc had indeed engineered a pump dump scheme after a phony reverse split.
Mr.Jaeger of Charles Schwab,by stating my questions were answered in 2002,lies outright.A perusal of their email communication with me in late 2002 will show I inquired at that time,(before removing my shares from my Schwab account by having Schwab purchase a 'certificate' for the few thousand post 'reverse split' shares I had left from the fraudulent Alexander Walker and his The Nevada Agency And Trust Company),whether Schwab was naked shorting me as Endovasc,James Dale Davidson,and 'famed trial attorney O'Quinn claimed.A Ms.or Mrs.Shapiro,I believe it was,from Schwab International Services would not answer me.So I requested she buy me that cert as Endovasc recommended.
All the while Schwab had helped the insiders load that account with shares to dump.As an example of how big the reverse split fraud was,if I had kept my shares from the reverse split as insiders and those running the pump dump out of that Schwab account did,my 550,000 shares would have been worth nearly $1 million dollars in July when the reverse split increased monetary value of each share 40 times over night !!!! And during James Dale Davidson's promo and tout a little later in and around November when the share price rose quickly to over $3 per share before collapsing those shares would have been easily over $1 1/2 million !!!
That is how my 'investment' in the U.S. was probably stolen and laundered offshore.And this gives some idea of how large the Endovasc pump dump alone through that Schwab account was.'Up to 30 million shares' !!!!! Just a million shares,say twice what I had before the fraudulent reverse split,would yield $3 million dollars if dumped on or around the time it hit $3 per share during James Dale Davidson's touting in late 2002 !!!
Perhaps this masking of shares that Endovasc and Schwab and the insider Schwab acount holders all knew about,as opposed to me who was kept in the dark and lied to in Endovasc press releases,was used for terrorism and or money laundering in general.No one would ever know because Schwab aids and abetts in covering up the pump dump and as a market maker benefits by knowing a large block indeed of shares will be dumped from a Schwab account,perhaps at prices already worked out with Schwab Capital market maker.Can anyone say conflict of interest ?
And the very transfer agent Endovasc 'management' and 'famed trial attorney O'Quinn' recomended to me as a place to entrust my remaining shares to protect from this pump dump they called a 'naked short' I would discover only in mid 2003,was an Endovasc 'insider' in 2003.He would receive $200,000 in Endovasc shares to dump on my already destroyed 'certificate' that I could not sell anyway.
..........................................................
email from Schwab and ,below,posted on offshorebusiness.com:
Schwab ignores LOM-Endovasc-Davidson Query
By naked shorted or dumped on from Schwab account? on 9/18/2004 5:54:46 PM
E-mail: biodog0@yahoo.com
Date: Thu, 16 Sep 2004 18:55:03 -0400 (EDT)
From: 'Charles Schwab and Co., Inc.' Add to Address Book
To: biodog0@yahoo.com
Subject: RE:Re: Charles Schwab and Co., Inc [#3291437]
Dear Mr. Ryals:
Thank you for your email. We appreciate your concern regarding the Yahoo message board. You are correct that the individual posting the messages is not the Chairman and CEO of the Charles Schwab Corporation. Unfortunately, there is no way for us to control message board user ID's.
In regard to your reference of communications with Charles Schwab & Co. dating back to 2002, the company considers those matters resolved.
Thank you for using Schwab's Email Customer Service.
Sincerely,
John Jaeger
Schwab Service Recovery Specialist
http://www.schwab.com
NOTICE: All email sent to or from the Charles Schwab corporate email system may be retained, monitored and/or reviewed by Schwab personnel.
(c)2004 Charles Schwab & Co., Inc., member SIPC/NYSE
--Original Message--
From: biodog0@yahoo.com
Date: 2004-09-15 00:00
To: webtrading@schwab.com
Cc: biodog0@yahoo.com
Subject: Re: Charles Schwab and Co., Inc [#3291437]
Content-type: text/plain ; charset = us-ascii
Dear Schwab,
I am writing from Guatemala.I would appreciate the receiver of this message to please forward this email to the Chairman's Division.It relates to communication(1 letter from Elias Torrez and another from Paul Hammon both of Chairman's Division) sent by that office in early 2002.Also this is to inform Charles Schwab that someone posts on yahoo sch messageboard not only under the pseudonym or alias of 'charles_r_schwab' but pretends to be him as you can see from the post below.My email to the Chairman's Division is immediately below that but both should be forwarded to them please.
from yahoo's sch message board :
Re: Schwab aids share-money laundering.e
by: charles_r_schwab (67/M) 09/10/04 02:48 am
Msg: 63182 of 63397
Mr. Ryals, Give me a call. I would like to discuss with you personally your situation. I have reviewed our files and I think you have your facts drastically wrong. I'd like to clarify a few things for you. I tried calling you but the number in your files says the number is disconnected and that there is no new number. Our records also indicate that you may have fled the country to avoid some legal issues regarding your allegations but we can ignore that for the time being. Bottom line is that I would like to answer your allegations man to man. If you are no longer able to afford a phone call, call me on my 800 number and ask for Chuck's private extension #57.
Posted as a reply to: Msg 63176 by biodog0
Dear Chairman's Division,I have been re-reading your two letters mentioned above of early 2003 which relate to a 'select client'(Schwab's or Endovasc's or boths ?) receiving a substantial number of shares into their account.To read between the lines of Mr.Hammond's letter where he states,'The exchange agreement indicated that the company(Endovasc) was offering to exchange......' Anyway it was an 'agreement'(you have it in your files),of May 2002,basically giving free shares into that account,(up to 30 million!!!),at a time a reverse split was being announced in pr releases to the regular shareholders that should have left no more than 3-5 million shares at most existent !!!
I have also become aware through the writing of DJ's Carol Remond in June of this year that LOM has a Schwab Capital account.(Is that separate from 'regular' client accounts at Schwab brokerage?)Nonetheless,it is a known fact that James Dale Davidson,who touted the stock and whose Agora publications is being litigated against by SEC at present for that very reason,(touting Endovasc,etc.in late 2002),was at one time a substantial shareholder of LOM of Bermuda and he recommended it in his book,'The Soveriegn Individual'.Also Mr.Hammon of the Chairman's Division states in his letter that the Chairman's Division first became aware of the exchange agreement on May 28, 2002 when 'one of our customers' forwarded it to you.So between the lines I take this to mean that ONLY ONE SCHWAB ACCOUNT RECEIVED AND WAS ALLOWED THIS AGREEMENT FROM ENDOVASC, RIGHT ? Was this account the LOM account Carol Remond mentioned in her June 2004 article ?
But most important to me is to know if that account receiving that free gift of shares,UNDER THIS'SHAREHOLDER AGREEMENT', dumped those shares in November 2002 when Mr.Davidson touted through his 'Vantage Point',(and who knows whatever other tout cyberfraud and mail fraud he created or has at his disposal)?
Upon receiving your letters and a copy of that shareholder agreement from you in the first part of 2003 and after the massive pump dump of November 2002,(that you can see in historic trades of Endovasc at the time),I felt it odd that Mr.Torrez threatened me with your legal staff if I continued to complain.However I felt certain you were going to report the transaction in retrospect to the SEC if not the FBI FOR POSSIBLE MONEY LAUNDERING,(AS OCCURED WITH JEFFREY SENGER USING ONE OF YOUR ACCOUNTS),knowing that it was a pump dump through a customer using a Schwab account !! Was this ever done ?( Mr.Senger,who dumped from one of your accounts and was convicted,is connected to Davidson,in a way,through a Brent Pierce who was involved with Senger but that's a different pump dump,although also through a Schwab account.)
I am just saying I have waited years,and as you know,I was conned into buying a 'cert' from Endovasc's insider transfer agent,Alexander Walker,who received a couple hundred thousand dollars of 'free' shares after Endovasc released a lieing businesswire pr claiming you were 'naked shorting' me so they could further confuse the issue of the pump dump from a Schwab account,as I now realise !!!
I am compiling my own past ragingbull evsc message board and yahoo sch message board posts plus the shareholder agreement you sent me and the letters into an article or complaint as to what occured to me.I have considered titling it,'How Charles Schwab Introduced Me To The International Penny Mafia'.I am the first to admit my stock ignorance and how the 'strong buy' dollar 'tech' stocks sent me overnight into penny scams.Yet Schwab made market in those stocks that criminals touted and lied to tout.Then laundered my money to I still don't know where.I just wish I could convince you to look and tell me where that $60,000 in Endovasc alone went.I would be forever greatful and say as much in my writing.I still do not understand why Mr.Torrez threatened me with your legal counsel rather than using that counsel to challenge those who ran a pump dump through a Schwab account as appears you can document in retrospect.
Sincerely,
Tony Ryals
............................................................
And these two press releases immediately following the pump dump out of that Schwab account and perhaps out of Refco and Ameritrade that 'famed trial attorney O'Quinn' mistook(?) for 'naked shorting'. Note these two press releases occured immediately following the Davidson 'AGORA-Vantage Point' tout or stock promotion of Davidson and subsequent dumping from the Schwab account,neither of which I was aware of at the time.This dear reader is where they conned me into buying a 'cert' from their fraudulent transfer agent and the time when Schwab was asked straight out if Endovasc was correct in claiming the 'naked shoerted me.Schwab refused to answer. :
Endovasc Announces Shareholder and Dividend Alert
Tuesday November 12, 7:30 am ET
MONTGOMERY, Texas--(BUSINESS WIRE)--Nov. 12, 2002--Endovasc (OTCBB:ENVC - News) - a biotechnology company with two new cardiovascular drugs approved for final FDA phase III trials -announced today that it has -- in the opinion of its consultants -- uncovered an oversold position in excess of 1,000,000 shares in the company's stock, held primarily by The Charles Schwab Corp. (NYSE:SCH - News), Ameritrade (Nasdaq:AMTD - News) and Refco. The findings are a result of an ongoing litigation intelligence work conducted in connection with the $216 million stock manipulation lawsuit filed by Endovasc and accepted on contingency basis by the legendary trial attorney John O'Quinn, who also won the record $17.3 billion dollar settlement for the State of Texas vs. Big Tobacco.
'The oversold position in our company's stock can actually be great news for our shareholders,' says Dr. David P. Summers, Chairman and Chief Executive Officer of Endovasc. 'The overselling in our stock in the past few weeks does not seem to have had a negative impact on our share price. But, if shareholders actually asked for physical delivery of the shares they bought, the market would probably have to pay a premium in order to deliver them.'
'Additionally, our Board has recently approved the issuance of a tracking stock dividend plan. But according to our plan, as approved, it won't be possible to issue any dividends to anyone that the company can't identify as a legal beneficial shareholder. This is why it is imperative that our shareholders contact their brokers to ask their stock to be taken out of the street form and put into physical form,' states Summers.
............................................................
This is from J.D.Davidson's 'Vantage Point' mail and cyber fraud publishing scam.Here he makes his infamous 'the SEC lies' speech and attacks Carol Remond for articles she has written criticizing his mainpulative involvement with Endovasc and Genemax.This was late 2002 or early 2003:
Dear Vantage Point Investor,
You may be as startled and upset as I am by the sudden collapse in the price of GeneMax (GMXX), which has tumbled in the last nine trading days. The question is, why? I can't pretend that I fully understand the answer. But I have a disturbing guess. It appears that the naked short-sellers who have counterfeited millions of GeneMax shares in an attempt to destroy the company have enlisted powerful help.
In theory, the Securities and Exchange Commission is a regulatory body charged with maintaining the integrity of public securities markets in the United States. In reality, the SEC is like any other government agency. It responds to powerful entrenched interests. It abhors bad publicity, rewards its friends and punishes its critics.
Unhappily, the SEC also lies. I know because the SEC field office in Utah has lied about me. And I suspect that these lies are the culmination of a carefully laid plan to discredit GeneMax and punish the company for raising troublesome issues about naked short selling, which has also embarrassed the SEC.
If you have been a subscriber to Vantage Point for any length of time, you are no doubt aware that I am a critic of 'electronic counterfeiting,' the process by which some investment banks, market makers and broker-dealers drive down the prices of Nasdaq Bulletin Board companies by selling unlimited quantities of shares they don't own. Since stock prices are determined by supply and demand, allowing unlimited counterfeiting of stock essentially guarantees that the stock becomes worthless.
Of course, a company whose shares are worthless won't last long. It is unable to raise money if its stock is worthless. All too often, such small companies are driven into oblivion by electronic counterfeiting. When we are slogging along with a weak economy, I consider it almost criminal negligence that the government would permit investment banks, market makers and broker-dealers to weaken the economy further by destroying small companies that could otherwise be a major fountain of growth.
Why would the government let this happen? I don't think it is necessarily a Grand Conspiracy with a capital 'G.' But the bad guys have managed to control most of the news about 'electronic counterfeiting.' And perversely, they also seem to have the regulators on their side.
I had a painful lesson in this reality at the beginning of this week when I learned to my astonishment that the Utah office of the SEC had tarnished my name by accusing me of failing to disclose an interest in two investments that I recommended in Vantage Point Investment Advisory. Their exact charge is as follows:
'Among the issuers promoted in this manner have been GeneMax Corp. and Endovasc Ltd., Inc. Davidson is an officer, director and, indirectly, a substantial shareholder of these two issuers. Neither the soliciting e-mail nor the subsequent company report discloses Davidson's relationship to the companies.'
This is total rubbish. I deny any impropriety. Indeed, the charges are remote from the facts. As you will know if you subscribed to Vantage Point last summer, I fully disclosed my role as a founder, director and officer of GeneMax when I recommended the company and its promising treatment for cancer. And I also disclosed a special relationship with Endovasc. I am not an officer or director of Endovasc. I have a few shares that I received in exchange for assigning my rights in what could be a valuable patent to the company.
To be sure that I wasn't missing something, I had my attorney review the record. He concluded that my disclosures are complete: 'I spent this afternoon reviewing Agora marketing copy for Vantage Point and the newsletters and have verified that the charge that you failed to disclose your personal interest in GeneMax is completely false.' Agora will be filing a motion to dismiss the SEC's baseless complaint.
I fail to see how anyone of good faith who reviewed the record could possibly construe it as the SEC apparently has. Although I can't prove it, I have concluded that the SEC, or at least some of its personnel, were more offended by my criticism of electronic counterfeiting than they are by the abuse itself -- which causes you and other investors hundreds of billions in losses. In fact, the costs of electronic counterfeiting are much higher than those entailed in the accounting scandals which have garnered so much attention. Nonetheless, instead of correcting these abuses, the SEC has gone out of its way to rope me into a doubtful complaint that they have developed against another Agora publication -- a product to which I have no connection other than a passive one as a minority shareholder in Agora.
Nor do I take it to be entirely a coincidence that while I have recommended more than 30 investments in Vantage Point over the past 16 months, my reputation is being tarred in respect to just two companies, GeneMax and Endovasc. These two companies have one thing in common, in addition to the fact that both have promising medical innovations that could ease much suffering and save many lives. Both have been at the forefront of legal action to combat the abuse of electronic counterfeiting of their shares. But these efforts have hardly earned them the friends they should. Rather than garnering applause, their efforts to confront the abuse of electronic counterfeiting of their shares has made both companies the focus of negative publicity.
In particular, one writer, Carol S. Remond, undertook to paint a negative picture of both companies, publishing what bordered on outright lies. For some reason known only to others, the SEC appears to have adopted Remond's text in defense of the electronic counterfeiters. In this respect, it is suggestive that the SEC apparently leaked its complaint about Agora to Remond, who cooperated by writing a story trumpeting the SEC's effort to discredit me and these good companies.
I wanted to write to you immediately when I got this startling news to tell you that I will not be cowed by these Machiavellian tactics. I will continue to raise important issues of investor protection that the SEC appears to wish to duck. I do so with faith that the truth will eventually triumph, the evil of electronic counterfeiting will be curtailed, and the integrity of public security markets restored.
Or to put it another way, if powerful people are so keen to discredit my criticism of electronic counterfeiting that they will orchestrate an entirely bogus charge of the kind carried on the wires against me this week, that itself indicates that more light needs to be shed on the shadowy activities they are trying to protect.
But, on to the status of your GeneMax holdings... Absolutely nothing about this company or its exciting immunotherapy development has changed and would warrant this share price decline. In fact, in an independent study commissioned by the company, it was determined that if GeneMax were funded as low as at $1.50 per share, and assuming that its products prove to work as well in humans as they have in animals, the present value of the stock would be $420 per share, notwithstanding dilution. GeneMax remains a fundamentally sound company and a tremendous buying opportunity at these levels. I recommend that you increase your GeneMax shares, as well as those in Endovasc (EVSC.OB). And, may I reiterate, I am a shareholder in both companies.
And, if you are as concerned as I am about electronic counterfeiting and its effects on the dynamic young companies that must fuel our country's future growth (as well as your portfolio), I urge you to write your congressman. You can also register your concern with the National Association Against Naked Short Selling (http://www.nakedshortselling.com),, which is taking up the fight for companies and investors alike.
Sincerely,
James Davidson
.........................................................
NOW HOW DID O'QUINN MISS THE MILLIONS BEING DUMPED BY DAVIDSON AND SUMMERS AND CANTRELL AND ONLY COUNT A SUPPOSED MEASELY MILLION BEING 'OVERSOLD' BY SCHWAB, ETRADE,ET.AL.? DID O'QUINN PERSONALLY,WILLFULLY ALLOW HIS NAME TO BE USED FOR FRAUD OR WAS IT ALL A BIG MISTAKE?
.........................................................
Endovasc Shareholder Alert
Thursday December 19, 2:38 pm ET
MONTGOMERY, Texas--(BUSINESS WIRE)--Dec. 19, 2002--Endovasc Ltd. Inc. (OTCBB:ENVC - News) -- a biotechnology company focused in the area of cardiovascular disease -- announced today that it believes the Company's stock has been shorted in the past few weeks, taking it down from $3 to the current $0.60 level.
Many of Endovasc's shareholders have contacted the Company during the last few days to express their concern on the significant drop in the Company's share price. Endovasc believes its shares are again being manipulated downward by a handful of short-sellers. The Company does not have any detailed evidence supporting this claim but has advised its attorney, John O'Quinn, to investigate the recent activity in the stock.
'It is important for our shareholders to know that we are fundamentally the exact same company as we were a few weeks ago when our stock was trading at $3.00. In fact, we have made further progress since then, as our recent press releases indicate,' says Dr. David P. Summers, chairman and chief executive officer of Endovasc Ltd. Inc.
COULD IT BE THAT THE 'HANDFUL OF SHORT SELLERS' WERE THOSE WHO GOT MILLIONS 'PREFERRED SHARES'FOR THEIR 'SPECIAL RELATIONSHIP' WITH THE 'COMPANY' AND THE OFFSHORES THEY DEALT WITH ?
.........................................................
This below from Brent Mudry in 2002,an excellent stock fraud investigator,formerly of Canada's StockWatch, shows clearly Schwab has had clients running pump dumps from Schwab accounts in the past .Thus Charles Schwab should be not only vigilant in this post 9/11 world but when a concerned customer has lost everything from a pump dump originating from one of their own accounts the past tells them they should investigate.
Not just because one of their customers lost everything in a stock purchase and because the Schwab account shows pattens of a pump dump than can be localised to on or around November 2002 but because it would not be the first time.
And Brent Pierce,mentioned below in association with that Schwab pump dump, just happened to be partner with James Dale Davidson who was touting Endovasc through his 'Vantage Point' 'pumpzine' when the dump of shares from that loaded Schwab account were dumped.
James Dale Davidson and his pals Grant Atkins and Brent Pierce, mentioned below, ran the 'NAANSS' SCAM with Mr.Davidson out of the Blaine,Washington Genemax office.Both dumping their Genemax and other penny frauds whose shares they manipulated and touted to defrauded shareholders,all the time pointing to market makers like Schwab,Ameritrade,etc,.all the while using those brokers' private accounts to dump their penny scam shares from.The naked short scam created a smoke screen for this insider pump dump scam.And market makers like Schwab, or particularly Schwab,were aware of what was happening.
Schwab wasn't 'naked shorting',insiders were dumping through a private Schwab account!!!
............................................................
From Brent Mudry:
'In 1995, Merit's Toronto head branch took a hit when regulators halted trading in Ultra Pure Water Systems (Canada) Inc., a wash-trading rig job involving controversial Vancouver promoter Gordon Brent Pierce. The Ultra Pure ring left $2.36-million in unpaid debits at seven brokerages when the Alberta Stock Exchange abruptly halted the stock in March, 1995, led by $960,000 in debits in UPW accounts handled by Merit broker Stephen Traub.
'Although Mr. Pierce's behind-the-scenes Ultra Pure involvement was first revealed by Stockwatch in April, 1995, rumours of Merit's million-dollar hit had already been the talk of Howe Street and Bay Street. A number of Mr. Pierce's fronts, including Ultra Pure president Grant Atkins and Harvey Gorsuch, key players in the promoter's former Vancouver Stock Exchange disaster, Cost-Miser Coupons, opened or dealt in dubious offshore accounts at Merit, although Mr. Pierce was careful to keep his name off any public documents for Ultra Pure.
'The Ultra Pure case was the feature of a major probe by the commercial crime section of the RCMP. The Mounties capped up a 13-month criminal investigation in April, 1996, with a recommendation that charges be laid, but a Crown prosecutor subsequently 'no-charged' the file, in a controversial decision. Mr. Pierce's long-time front, Mr. Atkins, is now busy with another dubious penny stock promotion, GeneMax, which targeted Vancouver brokerages Global Securities and Union Securities in a naked shorting suit on Sept. 4.
'Although Merit head Barry Kasman had the misfortune of watching his firm sink after being torpedoed by at least one barely supervised broker and a number of dubious offshore accounts, he went on to head Rampart, which now finds itself accused of failing to supervise its brokers, verify identities of offshore account clients and other compliance troubles, including failing to take acceptable antimoney-laundering measures.
'With Mr. Kasman at the helm, Rampart, like Merit before it, had the misfortune of attracting a number of dubious clients, none of whom are identified in the IDA's detailed 26-page notice of hearing.
'The latest notable Rampart client to be flushed out is Jeffrey Ray Senger, 36, of West Palm Beach, Fla., who was arrested by the FBI on Aug. 14 in Operation Bermuda Short. In a 23-page grand jury indictment, returned on May 21 in United States District Court for the Southern District of Florida, and unsealed the day after his arrest, Mr. Senger faces a total of 28 counts in two separate wire, mail and securities fraud conspiracy.
'Rampart is featured prominently in the first case, in which Mr. Senger faces 27 counts for masterminding the pump-and-dump rig job of Lifekeepers International, which included a small network of bribed brokers, from November, 1998, through March, 1999, which resulted in investor losses of $3-million. (All figures in U.S. cases are in U.S. dollars.) In the second, Mr. Senger was snared in Bermuda Short's bribed mutual fund manager sting, allegedly agreeing to pay a 50-per-cent kickback for an $8-million investment by the fictitious fund in Piccard Medical and International Stores.
'If convicted, Mr. Senger faces maximum statutory terms of imprisonment of five years for each count of mail, wire and securities fraud conspiracy, 10 years for securities fraud, and 20 years for money laundering.
'In a co-ordinated action, the United States Securities and Exchange Commission also named Mr. Senger in a civil complaint relating to a later pump-and-dump of Lifekeepers, from November, 1999, through February, 2000. His co-defendants in this action are broker Brad M. Nirenberg, 38, of Coral Springs, Fla., and Norman F. Piatti, 48, of West Palm Beach, Fla., the president and CEO of Lifekeepers.
'The identity of Mr. Senger's employer should have caused a few red lights to go off in Rampart's compliance department. Mr. Senger controlled a branch of Baxter Banks & Smith, a junky U.S. brokerage later shut down by regulators. (In the unrelated Maid Aide case, Las Vegas penny stock lawyer Max Tanner and a number of licenced and unlicenced Baxter Banks brokers, virtually all since convicted, used Howe Street brokerage Pacific International Securities, facing a landmark British Columbia Securities Commission hearing Oct. 7, as a key conduit for illicit offshore trading. A second Canadian brokerage is also believed to have been used by the Maid Aide ring, but was never identified in court filings.)
'The grand jury indictment claims Mr. Senger acquired large blocks of Lifekeepers shares from November, 1998, to January, 1999, directed Baxter Banks boiler room brokers to flog the stock in return for secret kickback commissions, manipulated the stock and dumped his shares through accounts at other brokerages, mainly Rampart and discount brokerage Charles Schwab.
'Once defendant Jeffrey Senger and other co-conspirators who are not named in this indictment finished liquidating their Lifekeepers stock, they would stop touting that stock and would cease offering further payoffs to the conspiring brokers for promoting and selling that stock to their clients. At that point, the conspiring brokers would generally stop soliciting customers to purchase Lifekeepers stock, and the market price for that stock would decrease substantially.'
'U.S. authorities claim that as a further part of the conspiracy, Mr. Senger's greased brokers agreed that they would not get paid by him if their brokerage clients sold their Lifekeepers shares before he gave the go-ahead. The indictment claims the brokers never told their clients their main motivation in touting Lifekeepers shares was the cash bribes Mr. Senger was paying them. Although Mr. Senger allegedly greased 'numerous' dirty brokers, none of these unindicted co-conspirators are identified.
'According to the indictment, between December, 1998, and January, 1999, Mr. Senger transferred 180,000 shares of Lifekeepers to a brokerage account in his name at Rampart, formerly known as Merit Investments. Starting a month earlier, he also deposited 285,000 shares into an account in his name at Charles Schwab. It is unclear when Mr. Senger opened his account at Rampart, and whether the brokerage's compliance staff ever wondered why a client in Florida would take such a keen interest in a brokerage in Toronto.
'While Mr. Senger had a smaller initial position at Rampart, it dominated his selling. The indictment claims Mr. Senger dumped 208,500 Lifekeepers shares through his Rampart account, but just 15,000 shares through his Schwab account.(end Brent Mudry)
SO DUMPING FROM A SCHWAB ACCOUNT WAS NOTHING NEW YET SCHWAB COVERED UP THE ENDOVASC PUMP DUMP FROM ONE OF THEIR OWN ACCOUNTS THEY COOPERATED WITH LOADING UP FOR ENDOVASC INSIDERS TO DEFRAUD MYSELF AND OTHER CONNED 'INVESTORS'.WHY ?
.............................................................
Schwab and 'LOM' and perhaps J.D Davidson Collusion ?
By tony ryals on 7/6/2004 1:09:49 AM
E-mail: biodog0@yahoo.com
Note that in letter below from Charles Schwab and in the copy of 'shareholder agreement' for 'select client' of Endovasc and presumably Schwab's,no name of account holder is given who received 'up to 30,000,000 shares' into a Schwab account in May 2002.
No money was required for these shares or exchange of shares from the 'select client'.At the same time a reverse split of 40 for 1 was occuring and would take effect in July 2002. This 'reverse split of approximately 100 million shares should not have left more than 3-4 million shares existent in all, yet a Schwab account was already being filled with up to 30 million shares !!!
Endovasc put out a businesswire pr assuring all
shareholders they would maintain their same 'proportionate percentage' of ownership as before the 'reverse split'.In late 2002 Mr.James Dale Davidson began his pump of Endovasc stock including a false claim,to my knowledge, of having co-authored a patent for the 'company' with 'Dr.' David P.Summers for which he supposedly received shares. But no SEC filing exists for this.
To my knowledge there was never a patent.Mr.Davidson never gave me a patent number when requested by me.In fact,in separate 'Vantage Point' pump or tout releases Mr.Davidson claimed to be a 'substantial shareholder' although the source of shares or quantity was never declared or explained.
Whether or not this has bearing on 'LOM' or whether the private Schwab account was separate from 'LOM' I believe that account dumped in late 2002 coincidental to Mr.Davidson's pump.I have asked Schwab repeatedly for an answer.None has been forthcoming.Ethically, as an account holder, defrauded by Davidson's pump and someone's dump, I believe SCHWAB OWES A YES OR NO ANSWER AS TO WHETHER THE ACCOUNT RECEIVING SHARES BELOW DUMPED AT OR ABOUT THE TIME OF DAVIDSON'S 'VANTAGE POINT' TOUTING OR NOT.
I also believe Schwab,the market maker, by knowledge of that accounts existence, while I was completely in the dark,had access to and trading advantage FROM insider knowledge while I was left completely in the dark as this pump dump went down.
To make the fraud even worse once the pump dump of late 2002 ran it's course Endovasc 'management' put out an additional pr and claimed their 'famed trial attorney O'Quinn' had discovered an 'oversold' or naked short position by Schwab,Ameritrade,AND Refco and that it was now nccessary to buy a cert from their transfer agent,Alexander Walker, and his natco transfer agency !!!
Schwab remained silent when I queried them leading me to believe the 'famed trial attorney'O'Quinn's assertions as advertised by Endovasc.Only later would I note Mr.Walker received $200,000 IN FREE SHARES FOR HIS PART IN THE SCAM AS AN 'INSIDER'.
I MIGHT ADD THAT PREVIOUS TO THIS 'EXPERIENCE' I HAD NO EXPERIENCE WITH STOCKS MUCH LESS PENNY STOCKS IN MY LIFE. NONETHELESS THIS DID NOT DETER SCHWAB FROM SELLING THEM TO ME WITH NO ADVICE,COUNSELING,OR WARNING WHATSOEVER OVER THE INTERNET WHERE THEY WERE TOUTED.AND SCHWAB,WAS THE MAJOR 'MARKET MAKER'IN THIS PENNY PUMP DUMP.I BELIEVE,IN RETROSPECT THIS WAS REQUIRED BY SEC REG 15-G,BUT I AM CERTAINLY NO EXPERT ON THAT EITHER.
Tony Ryals
.........................................................
FROM RECENT ARTICLE ON LOM BY CAROLE REMOND :
'As of January 2003, LOM had brokerage accounts with at least four U.S. brokerage firms, including Knight Securities LP, Paragon Capital Markets Inc., Wein Securities Corp. and Vfinance Investments Inc., the SEC said. The firm also has accounts at Sterne, Agee Capital Markets Inc. and Schwab Capital Markets LLC.'
from Carole Remond DJ's In The Money,June 2004
Could it be that Endovasc's 'Dr.' Summers' and Dwight Cantrell's deal with 'select client'to fill account with up to 30 million shares was none other than a 'LOM' account associated with James Dale Davidson's pump of Endovasc in late 2002 ?
...........................................................
Letter from Charles Schwab,early 2003:
Dear Mr.Ryals,
In your email(early 2003),you accuse Schwab of failing to mail the(ENVC) 14C document to you as a shareholder of record. Schwab uses a vendor to conduct most shareholder mailings received by an issuing corporation.Each issuing corporation may choose how they want to forward any mandatory documents to its shareholders.That responsibility lies solely on the issuing corporation and its delegates.In this case ENVC never provided Schwab with a document or instructions to mail any documents for ENVC to its shareholders of record as outlined in your emails.
In researching your allegation I found documents pertaining to an ENVC private offer that was forwarded to Schwab by another client holding ENVC shares in a Schwab account.The reason I share this with you is because I think it pertinent to your allegations and your persuit of the truth,what did Schwab know and when.
On May 28,2002 Schwab received a fax from a client about ENVC(see copy enclosed).Schwab confirmed the details of this document on May 29,2002 at 2:30pm with Dwight Cantrell CFO,Endovasc LTD.,INC.At that time Mr.Cantrell confirmed that the company was conducting a 'Private Offer'to accredited investors only.Endovasc stated that they would be responsible for the mailing to selected Shareholders.
Once informed of this Schwab's responsibility is solely passive. In your latest email you made a specific allegation that Schwab failed to perform on it's fiduciary duties duties,to you,our client.We take issue with this and demand that you stop with these types of allegations against the Charles Schwab Corporation.We reserve the right to take any legal action necessary if you do not stop immediately.
Mr.Ryals,it is clear through your emails that you feel that you have been wronged.May I suggest that you persue this issue through proper regulatory proceedings rather than an futile email campaign.Making unfounded allegations does not support your quest for satisfaction and may lead to legal action
against you.
Sincerely,
Eliaz Torrez
Schwab Chairman's Division
...........................................................
PARAGRAGH OF EXCHANGE AGREEMENT:
'The undersigned(Subsciber)hereby agrees to exchange,and Endovasc Ltd.,Inc.,a Nevada corporation(The 'Company')hereby agrees to issue and exchange with the Subscriber,the number of shares of the Company's $.001 par value common stock(the'Company Shares')set forth on the signature page hereof for Series B Convertible Preferred Stock,$.001 par value (the 'Preferred Stock')convertible in accordance with the terms thereof at the exchange ratio of one share of Preferred Stock for each ten shares of the Company Shares exchanged (The Exchange).The Certificate of Designations of Series B Convertible Preferred Stock,$.001 par value per share is annexed hereto as Exhibit A('Certificate Designation').(The Company Shares are sometimes referred to herein as the 'Shares' or 'Common Stock').(The Preferred Stock and Common Stock issuable upon conversion of the Preferred Stock are collectively referred to herein as ,the 'Securities').Upon acceptance of this agreemnent by the Subscriber,the Company shall issue and deliver to the Subscriber the Preferred Stock against receipt of certificates representing the Company Shares endorsed or with stock powers attached in proper form for transfer.This Exchange Agreement and other similar Exchange Agreements relate to the exchange of a maximum of 3,000,000 shares of Preferred Stock for a maximum of 30,000,000 shares of Company Shares......'
............................................................
So begins the deal that excludes regular shareholders and is sent only to 'select customers'while hiding and or not sending Nevada dissenters rights notification to as many as possible.Also offering an illegal appraisal price of .025 rather than the .04+ OR .05 THAT SHOULD HAVE BEEN OFFERED TO ANY SHAREHOLDER SEEKING TO OR KNOWING ABOUT THEIR DISSENTERS RIGHTS.This was all done for and to the benefit of the very shorters Dr.Summers and Canrtell claimed to be fighting.Thus starting a new round of debentures for the shorters.
And Dr.Summers and Cantrell knew the holders of those millions of shares were partners with or received their shares from, the very debenture dumpers,Balmore and Celeste,that had previously shorted 'regular' shareholders share value down to near nothing.As Cantrell stated, about 3 individuals got a 1 for 1 share exchange.And you can bet they were related to the offshore debenture shorters directly or to their associates.
Now it is time for Summers and Cantrell to acknowledge they lied and dfefrauded shareholders in repeating the very deals with shorters all over again.I do not neccessarily accept this document as final deal they made but that it represents their collusion with and protection of secrecy with the shorters.
I believe the shorters actually have been allowed to sale and dump since the reverse split they did not endure and thus a small hidden fortune was made by first increasing the value of each share 40 times(while regular shareholders lost that value overnight)and that those like Davidson,and his 'special relation to the Company'allowed him to fleece and defraud the regular shareholders even further.
I believe the SEC should open the records of Walker's The Nevada Agency and Trust and do a 'share audit'.And I believe James Dale Davidson should reveal his relation to the offshores and just exactly how many shares he got from whom and at what price.And if he did receive his shares from a patent he exchanged with the company regular shareholders deserve to know from both him and the Company,WHAT PATENT AND HOW MANY SHARES WERE EXCHANGED FOR THIS UNNAMED AND SO FAR UNREPORTTED PATENT.
So begins the deal that excludes regular shareholders and is sent only to 'select customers'while hiding and or not sending Nevada dissenters rights notification to as many as possible.Also offering an illegal appraisal price of .025 rather than the .04+ OR .05 THAT SHOULD HAVE BEEN OFFERED TO ANY SHAREHOLDER SEEKING TO OR KNOWING ABOUT THEIR DISSENTERS RIGHTS.This was all done for and to the benefit of the very shorters Dr.Summers and Canrtell claimed to be fighting.Thus starting a new round of debentures for the shorters.
............................................................
Is Schwab's relations to offshore clients in penny stocks and their pump dumps a conflict to 'regular' Schwab customers who,unlike Schwab, don't realise a pump dump is coming down ? I am now almost positive 'LOM' of Bermuda was the 'select client' Schwab filled the below account for with Endovasc's corrupt management's deal below.Schwab would never say but SEC investigation may be finally bringing this Endovasc,James Dale Davidson pump dump through Schwab account to light.
Those behind that first Endovasc pump dump I experienced appear to be related to the 'offshores' Balmore S.A. and Celeste Trust,mainly shells with shady people,(probably Europeans,Canadians, Americans and Israelis,not necessarily in that order.),engaged in discount penny stock share buying from desperate,or more often corrupt management, which Endovasc typifies. Then dumping shares,from the British Virgen Islands or Bermuda or the Caymans or some other Caribbean entity favorable to such slimy penny stock share and money laundering activities.
Or,as I've come to find out,with friendly brokers or combined 'broker-market makers' like Schwab Capital who buy and sell penny stocks as well as open private accounts for offshores to dump through as the stock is being touted or promoted through paid pr con men.A website called Penny Rocket may have been one of the tout promotors paid at that time,at least some ragingbull aliases touting on Endovasc's message board at the time mentioned it.
...........................................................
Within a few months of the late 2001 to early 2002 pump and dump and consequent rapid rise and crash back to near a 3 cent share price for Endovasc a 'reverse split would be announced that spring of 40 shares converted to one.So my over half million shares would now be converted to a few thousand.But note the lieing pr below telling me my 'proportionate percentage ownership',which was substantial,would remain:
Answers Shareholder Questions
MONTGOMERY, Texas, July 25 /PRNewswire-FirstCall/ -- Endovasc Ltd., Inc. (OTC Bulletin Board: ENVC) -- the Company behind the ANGIOGENIX(TM) treatment (a revolutionary way to facilitate 're-growth' of the heart tissue) announced two weeks ago that its shareholders approved a one-for-forty stock split of the Company's common stock. Since that announcement, the Company has completed the split and begun trading under its new ticker symbol, ENVC. After encouraging its shareholders to contact the Company with additional questions and suggestions, Endovasc has received numerous questions on various issues, including the reverse split and its impact on shareholders. Here is the synopsis of the most common questions and the Company's answers to them.
Q: What are your future plans for turning a profit?
A: It is important to remember that our industry -- biotech -- is extremely research and development intensive. This means that many biotech companies that are in the middle of the research cycle don't yet have any revenues. But as soon as drugs and treatments go through the FDA approval process -- and sometimes even before the process is completed -- these biotech companies can start generating significant revenue through licensing, royalty and distribution agreements.
We are very proud that we have been able to get two of our breakthrough drugs -- Liprostin(TM) and ANGIOGENIX(TM) all the way through to Phase III FDA trials. We have been extremely fiscally conservative. Our overhead is low, we have a very manageable debt, and we probably have one of the lowest, if not THE lowest burn rate of any companies in our industry that have ever brought two major products all the way through to Phase III trials.
Q: Can you expand on your revenue model?
A: Many investors are unaware of the fact that we may be able to start producing significant revenues even before the Phase III trials have been completed. Most investors don't seem to grasp how difficult it is to get drugs from a concept stage through to Phase III -- where we are now with our two major breakthrough treatments. Our revenue model directly affects our profitability and therefore our stock price. That's why we plan to issue a separate release describing our revenue model in more detail very soon.
Q: Where do you think your stock price will go?
A: As a public company, we can't make any stock price predictions. However, our market cap is less than $2 million, making our market cap one of the lowest in absolute dollar terms in the industry. Secondly, we have one of the lowest negative P/E ratios in the industry -- which again reflects our lean structure and fiscally responsible spending. Most other biotech companies are like Internet start-ups of the late 1990s in that they are losing millions and millions of dollars every year, even though they may not have two promising products ready for the Phase III, like Endovasc. Still, many have market caps of well above $100 million. Our current burn rate is still very low, and we are not planning to go on a spending spree even after obtaining additional funding.
Q: What does it mean that 'the reverse split will not affect any shareholder's proportionate interest in Endovasc'?
A: In a reverse split, the Company's total number of common shares outstanding went down by a factor of 40. Each shareholder now has one share for every 40 shares he/she owned before the split. This means that each of the shareholders still holds the same percentage ownership of Endovasc, even though the total number of outstanding shares has been reduced.
Q: Why did Endovasc undertake a reverse split? How will this benefit the Company's shareholders?
A: We are developing Endovasc with a long-term goal of gaining listing on Nasdaq or Amex -- as soon as we meet their listing requirements. In order to accomplish that, we need to focus on our fundamentals to maximize shareholder value in the long run.
We are working diligently to obtain additional funding. Funding will not only enable us to execute our future plans, but will also boost our net assets. Assets and stock price per share are some of the major listing requirements for both Nasdaq and Amex. We had almost 100 million shares outstanding prior to our split, which would have made it very difficult to reach Nasdaq SmallCap's minimum listing stock price of $4. With that many shares out, we would have needed a market cap of almost $400 million just to get listed.
In addition, many reputable funding sources, including institutional investors, do not typically invest in companies that are trading at pennies and have tens of millions of shares in the float. We believe that the reverse split has made our stock structure healthier and better positioned us to attract serious investors. In other words, we believe that these recent developments will really benefit our long-term shareholders who have made their investment decisions based on our fundamentals.
Q: The stock price has gone down since the reverse split. What do you plan to do about it?
A: Our current market cap is less than $2 million. This means that a company with two major breakthrough drugs in a $69 billion annual market is currently valued at just $2 million.
Small investors typically enter the stock market when stock prices are high and exit during mass panics when stock prices are low. We hope that our shareholders focus on the real progress that we are making instead of succumbing to panic because of the day-to-day stock prices.
About Endovasc:Endovasc is a biotechnology company that focuses on curing debilitating cardiovascular diseases resulting from arteriosclerosis (hardening of the arteries), diabetes, neurovascular and neurodegenerative disease, and congestive heart failure (CHF). The company has developed proprietary pioneering drugs and delivery technologies that deliver and release drugs to their intended targets by: (1) encapsulating drugs in 'germ-sized' microspheres called liposomes, which can target a single cell, and (2) small artificial metal and polymer scaffolds called vascular stents, which when placed in a blood vessel can restore the function of the artery to supply blood to blood-starved areas such as the area damaged by a heart attack.
Cardiovascular and diabetes markets account for more than USD 69 billion in sales volume per year -- 25% of the entire pharmaceutical market. Cardiovascular diseases are the number one cause of death in the western world today. They account for 50% of deaths worldwide, nearly double of those caused by cancer, the second most prevalent cause of death. Diabetes is the fastest growing disease in the United States. It is estimated that in the U.S. alone, the economic cost of these diseases is over USD 250 billion per year.
To sign up for shareholder alerts, please visit http://www.endovasc.com/html/e-list.html
The foregoing statements are made under the 'Safe Harbor' Private Securities Litigation Reform Act of 1995 and may contain forward-looking statements that involve risks and uncertainties that may not be evident at the time of this release. For more information about Endovasc, please visit www.endovasc.com . Please read the Company's filings with the Securities and Exchange Commission -- see www.freeedgar.com .
Contact Information: Investor Relations, Endovasc Ltd., Inc., email: InvestorRelations@endovasc.com
MAKE YOUR OPINION COUNT - Click Here
SOURCE Endovasc Ltd., Inc.
-0- 07/25/2002
/CONTACT: Investor Relations of Endovasc Ltd., Inc., InvestorRelations@endovasc.com/
/Web site: http://www.endovasc.com/html/e-list.html /
/Web site: http://www.endovasc.com /
................................
Submitted: 10/7/2004 3:36:56 PM
Modified: 10/7/2004 6:31:31 PMTony
Antigua, Central AmericaGuatemala
NAANSS or How Attorney O'Quinn Aided Massive Penny Stock Fraud and the 'Penny Mafia'
'Stop Naked shorting' became the cry of a number of fly by night websights.'NAANSS' or 'National Association Against Naked Short Selling' ran or operated out of the penny fraud company Genemax's Blaine,Washington office and 'investigatethesec.com' out of Vancouver, Canada were perhaps the two biggest promoters of this fraud.
Mainly,as it turns, out to mask their and their own clients' massive pumping then dumping of shares on naive and trusting investors such as myself.The 'NAANSS' site run by the far right political and securities fraudster James Dale Davidson and his Canadian convicted securities fraud partner Brent Pierce has since quietly closed down its website having made,no doubt,a substantial sum of millions of dollars conning investors not to sell but to go 'long' on the many penny company frauds while they quietly dumped millions of shares on their defrauded victims.
......................
Strangely,in December 2003,shortly after my SEC 'SHO' comments regarding Davidson et.al.'s 'naked short scam' appeared on Google search of 'NAANSS' from the sec.gov site, some of the tout aliases on ragingbull knowing it was me who sent it to the SEC began making cynical mention and posting the link.Then it disappeared from a google search entirely.I thought the sec decided to remove it.I sent a message informing them it had been removed.I received no reply but shortly thereafter it reappeared.As it turned out the 'naanss' fraudsters have now removed their own site in efforts to protect the guilty cyberfraudsters they are.I still think the fraudulent criminal mind of Mr.Davidson otherwise not being very clever or imaginative,named his 'gennemax' pump dump shell company for 'newsmax.com' that he brags about founding.
...................................
“If I were operating some sort of mafia in the United States, I would be only too delighted to have the leading voices of the news media insist to the public that many of my crimes could never have happened. It might even be worth hiring some goofballs to spread preposterous theories about nonexistent conspiracies in order to discredit persons who might stumble upon evidence of the real thing." — James Dale Davidson, Strategic Investment Newsletter, 7/25/95, commenting on the Susan Schmidt article in the Washington Post of 7/4/95.
..............................
So called 'famed trial attorney' John O'Quinn,knowingly or not, aided and abetted this fraud claiming it was true and litigating case after case and losing every one of them for lack of proof.But of course his real clients were not the vulnerable shareholders holding increasingly worthless shares as more and more were dumped into the market by these companies 'management''.And often these 'companies' had-have questionable if not mafiosi business ties and people with past criminal convictions or corrupt business practices.Attorney O'Quinn received a number of emails over this time from me alone warning him that he had not accounted for shares being obviously and brazenly dumped on investors by the very companies's management he defended against 'market makers'.And as much as he pretended to fight the market makers,virtually all his failed litigations were against the corrupt moneylenders these companies willingly took money from in the first place,not to support the companies they ran,but to put into their own pockets. ...........................
Attorney O'Quinn's clients were the real con artists and the investors O'Quinn did nothing for, holding their stock and trusting his honesty and legal background were the real victims.O'Quinn could never win in court and probably knew it because his own clients had signed the discount shares for loans to line their own pockets or launder offshore along with the touting loan sharks they often work with and for. Yes the Patriot Act and many laws already on the book that could deal with this criminal fraud aside,the SEC and Federal regulatory agencies seem to allow this massive fraud that can be used for money laundering to support any criminal or terrorist activity.
..........................
Below is Attorney O'Quinn's comments to SEC re 'naked shorting'.I find it difficult to believe Attorney O'Quinn did not know of the massive 'naked short scam' fraud his corrupt penny stock management clients were involved in using his name to promote their pump dump frauds.:
Comments of John M. O'Quinn, Esq. on Proposed Regulation SHO
January 5, 2004
Mr. Jonathan G. Katz, Secretary
Securities and Exchange Commission
450 Fifth Street, NW
Washington DC 20549-0609
Re: Proposed Regulation SHO
Dear Mr. Katz:
Over the last couple of years, I have been representing people who have been devastated by predatory and illegal short-selling. This illegal securities misconduct has been cleverly concealed by the perpetrators for years. Recently, the S.E.C. has acknowledged this reoccurring illegal conduct and taken some action. While those actions are a step in the right direction, they do not go far enough to protect vulnerable corporations and their legitimate stockholders from this pernicious activity. If, as a nation of laws, we do not act now and forcefully to stop this pernicious illegality and to protect such corporations and stockholders from it, our stock markets will be viewed by investors as corrupt and faith will be lost in our markets, both here and abroad. Naked short-selling destroys the value of the small innovative companies that have historically been the powerhouse of our American economy.
When we speak of “naked" shorting, we are referring the practice of selling shares short without fulfilling the obligation to deliver the shares to the purchaser. Opportunistic traders have learned how to take advantage of an overworked regulatory system to manipulate stock prices and profit from virtually riskless trading strategies.
These current recommendations are not strong enough to give the protection and relief to the hundreds of companies that have been, and continue to be, victimized by unscrupulous naked-shorting. Unless the system assures the public that every short position taken is backed by actual shares of the issuer there will be no effective restraint imposed upon these manipulators. We depend on the S.E.C. to protect these companies and ensure the integrity of the market. The time has come for true reform in this area.
Sincerely,
John M. O'Quinn, Esq.
O'Quinn, Laminack & Pirtle
Houston, Texas
................................
Attorn